登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 5290 条符合本次的查询结果， 用时 5.8193337 秒

401. Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial.

作者: Sheela Rao.;Emmanuelle Samalin-Scalzi.;Ludovic Evesque.;Meher Ben Abdelghani.;Federica Morano.;Amitesh Roy.;Laetitia Dahan.;Stefano Tamberi.;Amandeep Singh Dhadda.;Mark P Saunders.;Nathalie Casanova.;Rosine Guimbaud.;Astrid Lievre.;Joan Maurel.;Marwan Fakih.;Chuan Tian.;Jill Harrison.;Mark M Jones.;Mark Cornfeld.;Jean-Philippe Spano.;Pauline Rochefort.; .
来源: Lancet. 2025年405卷10495期2144-2152页
Retifanlimab has activity in programmed death ligand 1-positive advanced squamous cell anal carcinoma (SCAC) that has progressed on platinum chemotherapy. We aimed to prospectively assess the benefit of adding retifanlimab to initial carboplatin-paclitaxel for this disease.

402. Beyond deficit models in early childhood development science - Authors' reply.

作者: Catherine E Draper.;Günther Fink.;Dana C McCoy.;Milagros Nores.;Aisha K Yousafzai.
来源: Lancet. 2025年405卷10495期2127-2128页

403. Beyond deficit models in early childhood development science.

作者: Gabriel Scheidecker.;Tatek Abebe.;Seye Abimbola.;Nandita Chaudhary.;Willem E Frankenhuis.;Heidi Keller.;Yuko Munakata.;Bolajoko O Olusanya.;Dandara de Oliveira Ramos.;Muneera A Rasheed.
来源: Lancet. 2025年405卷10495期2127页

404. Digital acceptance and commitment therapy for fibromyalgia - Authors' reply.

作者: Lesley Arnold.;R Michael Gendreau.;Lance M McCracken.;Ben Vaughn.;Michael J Rosenbluth.
来源: Lancet. 2025年405卷10495期2126-2127页

405. Digital acceptance and commitment therapy for fibromyalgia.

作者: Dan Shan.
来源: Lancet. 2025年405卷10495期2125-2126页

406. The burden of unstable fractures in axial spondyloarthritis.

作者: Nathan Beucler.
来源: Lancet. 2025年405卷10495期2124-2125页

407. The revised Declaration of Helsinki protects healthy volunteers.

作者: Jack S Resneck.;Urban Wiesing.;Dominique Sprumont.;Johannes J M van Delden.;Ramin W Parsa-Parsi.;Amber R Comer.;Jake Young.;Otmar Kloiber.
来源: Lancet. 2025年405卷10495期2123-2124页

408. Bridging the gap in radiotherapy access in Kenya.

作者: Monicah Kitonga.;Marlene Koskei.;Lamech Koibarak.;Lincoln Sheets.
来源: Lancet. 2025年405卷10495期2122-2123页

409. Human reproduction in crisis: causes unknown.

作者: Niels E Skakkebaek.;Lærke Priskorn.;Rune Lindahl-Jacobsen.;Anna-Maria Andersson.;David M Kristensen.;Astrid Linnea Beck.;Lise Aksglaede.;Margit Bistrup Fischer.;Luiz R Franca.;Anders Juul.
来源: Lancet. 2025年405卷10495期2121-2122页

410. New evidence for common practices in carpal tunnel syndrome.

作者: Malin Zimmerman.;Lars B Dahlin.
来源: Lancet. 2025年405卷10495期2107-2109页

411. First-line immunotherapy combination in squamous cell anal carcinoma: hope in a neglected disease.

作者: Erika Martinelli.;Giulia Martini.
来源: Lancet. 2025年405卷10495期2106-2107页

412. Lurbinectedin with atezolizumab maintenance therapy in extensive-stage small-cell lung cancer.

作者: Noura J Choudhury.;Marina C Garassino.
来源: Lancet. 2025年405卷10495期2104-2106页

413. The uncertain future of migrant and refugee health.

作者: The Lancet.
来源: Lancet. 2025年405卷10495期2103页

414. Samuel S Myers: planetary health champion.

作者: Udani Samarasekera.
来源: Lancet. 2025年

415. Assessing generative artificial intelligence for mental health.

作者: John Torous.;Eric J Topol.
来源: Lancet. 2025年

416. King Kennard Holmes.

作者: Andrew Green.
来源: Lancet. 2025年406卷10498期24页

417. Reinforcing social safety for transgender and non-binary communities amidst global legislative threats.

作者: Arjee Javellana Restar.;Carlos E Rodriguez-Diaz.;Aaron S Breslow.;Wesley Correll-King.;Trace Kershaw.;Don Operario.;Kristi Gamarel.
来源: Lancet. 2025年406卷10499期110-113页

418. Disturbed sleep.

作者: Kate Womersley.
来源: Lancet. 2025年

419. Department of Error.

来源: Lancet. 2025年405卷10496期2204页

420. A death foretold.

作者: Vikram Patel.
来源: Lancet. 2025年
共有 5290 条符合本次的查询结果， 用时 5.8193337 秒